
Capital Raising & Corporate Finance
Pharmaceutical Giant Sees Largest-Ever Bond Sale
Pfizer’s eight tranches of notes, priced from $3 billion to $6 billion each, will mature between 2025 and 2063.
Global news and insight for corporate financial professionals
Join the global community of corporate and public-sector finance industry leaders reading Global Finance monthly in print.
Click HereCapital Raising & Corporate Finance
Capital Raising & Corporate Finance
Capital Raising & Corporate Finance
Capital Raising & Corporate Finance
Capital Raising & Corporate Finance
Features
Banking
Award Winners
Banking
Capital Raising & Corporate Finance
Capital Raising & Corporate Finance
Capital Raising & Corporate Finance